Logo image of XRX

XEROX HOLDINGS CORP (XRX) Stock Fundamental Analysis

NASDAQ:XRX - Nasdaq - US98421M1062 - Common Stock - Currency: USD

4.345  +0.14 (+3.45%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to XRX. XRX was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. XRX may be in some trouble as it scores bad on both profitability and health. XRX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year XRX has reported negative net income.
In the past year XRX had a positive cash flow from operations.
XRX had negative earnings in 4 of the past 5 years.
XRX had a positive operating cash flow in each of the past 5 years.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B 1.5B

1.2 Ratios

With a Return On Assets value of -16.18%, XRX is not doing good in the industry: 65.63% of the companies in the same industry are doing better.
XRX has a Return On Equity (-107.49%) which is in line with its industry peers.
Looking at the Return On Invested Capital, with a value of 1.60%, XRX is in line with its industry, outperforming 46.88% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for XRX is significantly below the industry average of 16.63%.
Industry RankSector Rank
ROA -16.18%
ROE -107.49%
ROIC 1.6%
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)2.67%
ROIC(5y)2.81%
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

The Operating Margin of XRX (2.12%) is comparable to the rest of the industry.
XRX's Operating Margin has declined in the last couple of years.
XRX has a Gross Margin (30.35%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of XRX has declined.
Industry RankSector Rank
OM 2.12%
PM (TTM) N/A
GM 30.35%
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XRX is destroying value.
Compared to 1 year ago, XRX has more shares outstanding
The number of shares outstanding for XRX has been reduced compared to 5 years ago.
XRX has a worse debt/assets ratio than last year.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that XRX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.46, XRX perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
XRX has a debt to FCF ratio of 13.05. This is a negative value and a sign of low solvency as XRX would need 13.05 years to pay back of all of its debts.
XRX has a Debt to FCF ratio (13.05) which is in line with its industry peers.
XRX has a Debt/Equity ratio of 2.61. This is a high value indicating a heavy dependency on external financing.
XRX has a worse Debt to Equity ratio (2.61) than 71.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF 13.05
Altman-Z 1.46
ROIC/WACC0.28
WACC5.78%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.46 indicates that XRX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.46, XRX perfoms like the industry average, outperforming 46.88% of the companies in the same industry.
A Quick Ratio of 1.10 indicates that XRX should not have too much problems paying its short term obligations.
XRX has a Quick ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.1
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -107.26%.
The earnings per share for XRX have been decreasing by -25.94% on average. This is quite bad
XRX shows a decrease in Revenue. In the last year, the revenue decreased by -4.97%.
XRX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.26% yearly.
EPS 1Y (TTM)-107.26%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-320.69%
Revenue 1Y (TTM)-4.97%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%-0.13%

3.2 Future

The Earnings Per Share is expected to grow by 5.31% on average over the next years.
The Revenue is expected to decrease by -0.46% on average over the next years.
EPS Next Y-20.83%
EPS Next 2Y25.06%
EPS Next 3Y5.31%
EPS Next 5YN/A
Revenue Next Year0.37%
Revenue Next 2Y7.33%
Revenue Next 3Y-1.42%
Revenue Next 5Y-0.46%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B 20B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for XRX. In the last year negative earnings were reported.
XRX is valuated cheaply with a Price/Forward Earnings ratio of 2.89.
XRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. XRX is cheaper than 90.63% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of XRX to the average of the S&P500 Index (33.87), we can say XRX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 2.89
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, XRX is valued a bit cheaper than 78.13% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, XRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 1.81
EV/EBITDA 9.95
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.06%
EPS Next 3Y5.31%

5

5. Dividend

5.1 Amount

XRX has a Yearly Dividend Yield of 1.92%.
The stock price of XRX dropped by -24.19% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
XRX's Dividend Yield is rather good when compared to the industry average which is at 1.98. XRX pays more dividend than 84.38% of the companies in the same industry.
XRX's Dividend Yield is comparable with the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

The dividend of XRX has a limited annual growth rate of 0.72%.
XRX has paid a dividend for at least 10 years, which is a reliable track record.
As XRX did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)0.72%
Div Incr Years0
Div Non Decr Years6
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

XRX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of XRX is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-8.91%
EPS Next 2Y25.06%
EPS Next 3Y5.31%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

XEROX HOLDINGS CORP

NASDAQ:XRX (8/12/2025, 1:42:12 PM)

4.345

+0.14 (+3.45%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)07-31 2025-07-31/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners96.49%
Inst Owner Change0.3%
Ins Owners7.68%
Ins Owner Change14.18%
Market Cap546.56M
Analysts50.91
Price Target10.41 (139.59%)
Short Float %18.87%
Short Ratio5.92
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend1.14
Dividend Growth(5Y)0.72%
DP-8.91%
Div Incr Years0
Div Non Decr Years6
Ex-Date06-30 2025-06-30 (0.025)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-495.05%
Min EPS beat(2)-892.08%
Max EPS beat(2)-98.02%
EPS beat(4)0
Avg EPS beat(4)-268.42%
Min EPS beat(4)-892.08%
Max EPS beat(4)-32.32%
EPS beat(8)1
Avg EPS beat(8)-147.42%
EPS beat(12)4
Avg EPS beat(12)-77.28%
EPS beat(16)7
Avg EPS beat(16)-65.19%
Revenue beat(2)1
Avg Revenue beat(2)-1.37%
Min Revenue beat(2)-3.7%
Max Revenue beat(2)0.96%
Revenue beat(4)2
Avg Revenue beat(4)-2.03%
Min Revenue beat(4)-7%
Max Revenue beat(4)1.64%
Revenue beat(8)2
Avg Revenue beat(8)-2.53%
Revenue beat(12)3
Avg Revenue beat(12)-1.95%
Revenue beat(16)4
Avg Revenue beat(16)-1.9%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.55%
EPS NY rev (1m)0%
EPS NY rev (3m)-24.18%
Revenue NQ rev (1m)15.8%
Revenue NQ rev (3m)17.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.48%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 2.89
P/S 0.09
P/FCF 1.81
P/OCF 1.49
P/B 0.41
P/tB N/A
EV/EBITDA 9.95
EPS(TTM)-0.09
EYN/A
EPS(NY)1.5
Fwd EY34.56%
FCF(TTM)2.4
FCFY55.26%
OCF(TTM)2.92
OCFY67.15%
SpS49.08
BVpS10.62
TBVpS-6.92
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.18%
ROE -107.49%
ROCE 2.03%
ROIC 1.6%
ROICexc 1.73%
ROICexgc 2.73%
OM 2.12%
PM (TTM) N/A
GM 30.35%
FCFM 4.89%
ROA(3y)-6.33%
ROA(5y)-4.27%
ROE(3y)-37.8%
ROE(5y)-24.09%
ROIC(3y)2.67%
ROIC(5y)2.81%
ROICexc(3y)2.95%
ROICexc(5y)3.28%
ROICexgc(3y)5.26%
ROICexgc(5y)5.88%
ROCE(3y)3.38%
ROCE(5y)3.56%
ROICexcg growth 3Y-8.95%
ROICexcg growth 5Y-26.16%
ROICexc growth 3Y-9.42%
ROICexc growth 5Y-24.96%
OM growth 3Y-20.2%
OM growth 5Y-27.38%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.91%
GM growth 5Y-4.79%
F-Score4
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 2.61
Debt/FCF 13.05
Debt/EBITDA 8.62
Cap/Depr 23.81%
Cap/Sales 1.05%
Interest Coverage 250
Cash Conversion 90.84%
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.1
Altman-Z 1.46
F-Score4
WACC5.78%
ROIC/WACC0.28
Cap/Depr(3y)17.3%
Cap/Depr(5y)18.56%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-107.26%
EPS 3Y-14.01%
EPS 5Y-25.94%
EPS Q2Q%-320.69%
EPS Next Y-20.83%
EPS Next 2Y25.06%
EPS Next 3Y5.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.97%
Revenue growth 3Y-4.03%
Revenue growth 5Y-7.26%
Sales Q2Q%-0.13%
Revenue Next Year0.37%
Revenue Next 2Y7.33%
Revenue Next 3Y-1.42%
Revenue Next 5Y-0.46%
EBIT growth 1Y-33.16%
EBIT growth 3Y-23.42%
EBIT growth 5Y-32.65%
EBIT Next Year77.35%
EBIT Next 3Y35.45%
EBIT Next 5Y20.31%
FCF growth 1Y-1.95%
FCF growth 3Y-5.93%
FCF growth 5Y-18.11%
OCF growth 1Y4.56%
OCF growth 3Y-6.69%
OCF growth 5Y-17.45%